Pharmacometrics in the Era of Personalized Medicine

来源 :第五届定量药理学与新药评价国际会议 | 被引量 : 0次 | 上传用户:cyh
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Outline ·Office of Clinical Pharmacology and Division of Pharmacometrics ·Case study-Edoxaban ·Summary New Era of Precision Medicine "Tonight, Im launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes—and to give all of us access to the personalized information we need to keep ourselves and our families healthier."
其他文献
会议
会议
会议
Outline · Introduction The basic concept of viral dynamic model · Case study Integrated Population PK/PD Modeling of Lopinavir/Ritonavir in HIV-1 Treatment-Na
会议
会议
Systems Modeling for Translational Pharmacology Small Molecule Inhibitors of FLT3, CDK4/6 or Both Plasma PK Results Cellular Signaling Modeling Scheme pSTAT5 Da
会议
会议
  Aims: To choose a vancomycin population pharmacokinetic model most suitable for Chinese pediatric patients,in order to guide the dosage adjustment.Methods:
会议
Mechanism based models are already used widely in the design of first in man studies Physiologically based pharmacokinetics (PBPK) · Routine in Roche to suppor
会议